BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 16785519)

  • 1. IL-18 bridges innate and adaptive immunity through IFN-gamma and the CD134 pathway.
    Maxwell JR; Yadav R; Rossi RJ; Ruby CE; Weinberg AD; Aguila HL; Vella AT
    J Immunol; 2006 Jul; 177(1):234-45. PubMed ID: 16785519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct modulatory effects of LPS and CpG on IL-18-dependent IFN-gamma synthesis.
    Gould MP; Greene JA; Bhoj V; DeVecchio JL; Heinzel FP
    J Immunol; 2004 Feb; 172(3):1754-62. PubMed ID: 14734758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IFN-alpha and IL-12 induce IL-18 receptor gene expression in human NK and T cells.
    Sareneva T; Julkunen I; Matikainen S
    J Immunol; 2000 Aug; 165(4):1933-8. PubMed ID: 10925275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-18 contributes to host resistance against infection with Cryptococcus neoformans in mice with defective IL-12 synthesis through induction of IFN-gamma production by NK cells.
    Kawakami K; Koguchi Y; Qureshi MH; Miyazato A; Yara S; Kinjo Y; Iwakura Y; Takeda K; Akira S; Kurimoto M; Saito A
    J Immunol; 2000 Jul; 165(2):941-7. PubMed ID: 10878369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TNF enhances CD4+ T cell alloproliferation, IFN-gamma responses, and intestinal graft-versus-host disease by IL-12-independent mechanisms.
    Brown GR; Lee EL; Thiele DL
    J Immunol; 2003 May; 170(10):5082-8. PubMed ID: 12734353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of STAT4-dependent and independent mechanisms of resistance to Toxoplasma gondii.
    Cai G; Radzanowski T; Villegas EN; Kastelein R; Hunter CA
    J Immunol; 2000 Sep; 165(5):2619-27. PubMed ID: 10946290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic engagement of an ineffective endogenous anti-tumor immune response and induction of IFN-gamma and Fas-ligand-dependent tumor eradication by combined administration of IL-18 and IL-2.
    Wigginton JM; Lee JK; Wiltrout TA; Alvord WG; Hixon JA; Subleski J; Back TC; Wiltrout RH
    J Immunol; 2002 Oct; 169(8):4467-74. PubMed ID: 12370382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bystander activation of CD8+ T cells contributes to the rapid production of IFN-gamma in response to bacterial pathogens.
    Lertmemongkolchai G; Cai G; Hunter CA; Bancroft GJ
    J Immunol; 2001 Jan; 166(2):1097-105. PubMed ID: 11145690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A signal through OX40 (CD134) allows anergic, autoreactive T cells to acquire effector cell functions.
    Lathrop SK; Huddleston CA; Dullforce PA; Montfort MJ; Weinberg AD; Parker DC
    J Immunol; 2004 Jun; 172(11):6735-43. PubMed ID: 15153490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The production of IFN-gamma by IL-12/IL-18-activated macrophages requires STAT4 signaling and is inhibited by IL-4.
    Schindler H; Lutz MB; Röllinghoff M; Bogdan C
    J Immunol; 2001 Mar; 166(5):3075-82. PubMed ID: 11207258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased entry into the IFN-gamma effector pathway by CD4+ T cells selected by I-Ag7 on a nonobese diabetic versus C57BL/6 genetic background.
    Koarada S; Wu Y; Ridgway WM
    J Immunol; 2001 Aug; 167(3):1693-702. PubMed ID: 11466393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A unique mechanism for innate cytokine promotion of T cell responses to viral infections.
    Pien GC; Nguyen KB; Malmgaard L; Satoskar AR; Biron CA
    J Immunol; 2002 Nov; 169(10):5827-37. PubMed ID: 12421964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination with tumor peptide in CpG adjuvant protects via IFN-gamma-dependent CD4 cell immunity.
    Stern BV; Boehm BO; Tary-Lehmann M
    J Immunol; 2002 Jun; 168(12):6099-105. PubMed ID: 12055220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-1 receptor-associated kinase 4 is essential for IL-18-mediated NK and Th1 cell responses.
    Suzuki N; Chen NJ; Millar DG; Suzuki S; Horacek T; Hara H; Bouchard D; Nakanishi K; Penninger JM; Ohashi PS; Yeh WC
    J Immunol; 2003 Apr; 170(8):4031-5. PubMed ID: 12682231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of virus-specific CD8+ T cells by lipopolysaccharide-induced IL-12 and IL-18.
    Raué HP; Brien JD; Hammarlund E; Slifka MK
    J Immunol; 2004 Dec; 173(11):6873-81. PubMed ID: 15557182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paracrine release of IL-12 stimulates IFN-gamma production and dramatically enhances the antigen-specific T cell response after vaccination with a novel peptide-based cancer vaccine.
    Salem ML; Kadima AN; Zhou Y; Nguyen CL; Rubinstein MP; Demcheva M; Vournakis JN; Cole DJ; Gillanders WE
    J Immunol; 2004 May; 172(9):5159-67. PubMed ID: 15100252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphocytes from autoimmune MRL lpr/lpr mice are hyperresponsive to IL-18 and overexpress the IL-18 receptor accessory chain.
    Neumann D; Del Giudice E; Ciaramella A; Boraschi D; Bossù P
    J Immunol; 2001 Mar; 166(6):3757-62. PubMed ID: 11238617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-21 in synergy with IL-15 or IL-18 enhances IFN-gamma production in human NK and T cells.
    Strengell M; Matikainen S; Sirén J; Lehtonen A; Foster D; Julkunen I; Sareneva T
    J Immunol; 2003 Jun; 170(11):5464-9. PubMed ID: 12759422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. OX40 ligation on activated T cells enhances the control of Cryptococcus neoformans and reduces pulmonary eosinophilia.
    Humphreys IR; Edwards L; Walzl G; Rae AJ; Dougan G; Hill S; Hussell T
    J Immunol; 2003 Jun; 170(12):6125-32. PubMed ID: 12794142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A heritable defect in IL-12 signaling in B10.Q/J mice. I. In vitro analysis.
    Ortmann R; Smeltz R; Yap G; Sher A; Shevach EM
    J Immunol; 2001 May; 166(9):5712-9. PubMed ID: 11313413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.